Huber Needle Market Is Expected To Generate Huge Profits by 2020

Huber needles are hollow needles that have slant tips to make it easy to go through the skin. Huber needles are used in chemotherapy, drug delivery, transfusions and blood samplings through the implanted port septum which is surgically rooted into the skin. They come in several sizes to fit the patient. With a Huber needle, the patient does not have to endure multiple needle sticks. They also protect clinicians from needle stick injuries.

Request to view Report Page : http://www.persistencemarketresearch.com/market-research/huber-needle-market.asp

Huber needles are off two types: straight Huber needles and curved Huber needles. The straight needles are mostly used in administration of injections. Curved needles are used in administration of nutritional fluids, chemotherapy fluids and medications like antibiotics.

The global Huber needle market is categorized based on their types, therapeutic applications and by end users. The type segment is further sub-segmented into straight and curved. The therapeutic segment includes chemotherapy, blood transfusions, dialysis and antibiotics administration. The end user segment is further sub-segmented into academic colleges, general hospitals, public hospitals and cancer hospitals.

In terms of geographic, North America and Europe dominates the global Huber needles market due to increasing prevalence of breast cancer. The U.S. represents the largest market for Huber needles followed by Canada in North America. In Europe, France, Germany and Italy holds major share of Huber needle market. However, Asia is expected to show high growth rates in the next five years in global Huber needle market due to rising awareness among people towards cancers and their treatment. China and India are expected to be the fastest growing Huber needle market in Asia. In Latin America, Brazil is the largest market for Huber needles. Brazil has the largest private health insurance compared to other Latin American countries. The expansion of private health insurance in the country has increases the demand of medical equipments for better healthcare services.

In recent time, increasing prevalence of cancer is key driving factor for the global Huber needle market. For instance, according to the International Agency for Research on Cancer (IARC), a specialized agency of the WHO, an estimated 12.7 million new cancer cases were reported in 2008 and the number reached 14.1 million in 2012. This increasing prevalence of cancer has resulted in significant rise in the demand of Huber needles for their chemotherapy treatment. In addition, advanced features of Huber needles is also supporting in growth of the global Huber needle market. However, high risks of complications associated with administration of drug delivery by Huber needles obstruct the growth of the global Huber needle market.

Request for Sample Report and Table of content @ : http://www.persistencemarketresearch.com/toc/3291

Some of the major companies operating in the global Huber needle market are B. Braun Medical, C. R. Bard, Perouse, Thiebaud, Smiths Medical and Vygon.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com

This release was published on openPR.